Production (Stage)
Dr. Reddy's Laboratories Limited
RDY
$15.80
-$0.37-2.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 184.13M | 167.32M | 149.86M | 166.87M | 157.40M |
| Total Depreciation and Amortization | 52.61M | 55.87M | 47.46M | 45.67M | 44.71M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.63M | -30.59M | 6.83M | 46.84M | -30.12M |
| Change in Net Operating Assets | 6.75M | -114.22M | -92.93M | -157.53M | -33.26M |
| Cash from Operations | 254.12M | 78.37M | 111.22M | 101.85M | 138.73M |
| Capital Expenditure | -88.52M | -85.19M | -89.97M | -61.26M | -63.15M |
| Sale of Property, Plant, and Equipment | -115.50K | 1.31M | 2.52M | 2.40M | 638.30K |
| Cash Acquisitions | -19.12M | 0.00 | -614.12M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.90M | 19.26M | 473.89M | -183.87M | -74.17M |
| Cash from Investing | -153.66M | -64.62M | -227.68M | -242.73M | -136.68M |
| Total Debt Issued | -4.89B | 1.83B | 16.99B | 10.57B | 375.00M |
| Total Debt Repaid | -253.00M | -306.00M | -435.00M | -300.00M | -266.00M |
| Issuance of Common Stock | 11.00M | 25.00M | 138.00M | 19.00M | 31.00M |
| Repurchase of Common Stock | -1.39B | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | 0.00 | -79.53M | -- | 0.00 |
| Other Financing Activities | -846.00M | -956.00M | 6.12B | -744.00M | -673.00M |
| Cash from Financing | -85.15M | 6.98M | 192.81M | 114.37M | -6.42M |
| Foreign Exchange rate Adjustments | 2.72M | -59.20K | -274.60K | 203.80K | -782.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.03M | 20.68M | 76.07M | -26.30M | -5.15M |